Ticker Details
Curis, Inc. Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers. Its pipeline products include CUDC-907, CA-170, CA-4948, CA-327, and Erivedge.
IPO Date:	August 1, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$15.2M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 3.59%
Avg Daily Range (30 D):	$0.04 | 3.99%
Avg Daily Range (90 D):	$0.04 | 3.73%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	.33M
Avg Daily Volume (90 D):	.36M

Trade Size
Avg Trade Size (Sh.):	46
Avg Trade Size (Sh.) (30 D):	401
Avg Trade Size (Sh.) (90 D):	345

Institutional Trades
Total Institutional Trades:	619
Avg Institutional Trade:	$1.7M
Avg Institutional Trade (30 D):	$1.07M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.22M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	16.83K

News

Aug 5, 2025 @ 10:10 PM Curis (CRIS) Q2 Loss Narrows 66% Source: Jesterai

Jul 11, 2024 @ 10:09 AM VISTA Inhibitor Clinical Trials Drug Approval Insi... Source: Kuick Research

Apr 12, 2024 @ 12:34 PM Top 3 Health Care Stocks That May Collapse In Q2 Source: Avi Kapoor

Apr 5, 2024 @ 12:43 PM Strength Seen in Curis (CRIS): Can Its 19.5% Jump ... Source: Zacks Equity Research

Feb 9, 2024 @ 1:11 PM CyberArk Software To Rally Around 19%? Here Are 10... Source: Avi Kapoor

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.3	$-.49	$-.68
Diluted EPS	$-3.3	$-.49	$-.68
Revenue	$11.65M	$3.18M	$2.75M
Gross Profit
Net Income / Loss	$-36.56M	$-7.73M	$-8.59M
Operating Income / Loss	$-34.33M	$-6.92M	$-8.25M
Cost of Revenue
Net Cash Flow	$-.86M	$M	$M
PE Ratio

Splits
Sep 29, 2023	1:20
May 30, 2018	1:5